Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Legal

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Legal
  • News

‘Amazon’s Latest Actions Against Fake Review Brokers: Amazon Targets The Source Of Fake Reviews With New Lawsuits’

By Happy Mohamed
June 28, 12:12 PM
https://www.aboutamazon.com/news/policy-news-views/amazons-latest-actions-against-fake-review-brokers Amazon invests significant resources to proactively stop fake reviews before being seen by a customer. June 27,

AMZN

Read More
1 minute read
  • Legal
  • News

Biora Therapeutics Announces New Patents For NaviCap Targeted Oral Delivery Platform

By Benzinga Newsdesk
June 28, 8:33 AM
The European Patent Office has issued European Patent No. EP3554539B1 entitled "Treatment of a disease of the gastrointestinal tract with an integrin inhibitor," European Patent No. EP3554485B1 entitled "Treatment of a

BIOR

Read More
2 minute read
  • Cannabis
  • Global
  • Guidance
  • Legal
  • Management
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

UK Greenlights Phase 2 Clinical Trial On Mindset Pharma’s Psilocin Drug For Major Depression

By Lara Goldstein
June 27, 3:54 PM
Drug discovery company Mindset Pharma (OTCQB: MSSTF) received approval from the U.K.

MSSTF

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Johnson & Johnson’s Talc Cancer Claims Saga: $8.9B Settlement Under Scrutiny

By Vandana Singh
June 27, 1:43 PM
Johnson & Johnson's (NYSE: JNJ) proposed $8.9 billion settlement of lawsuits alleging cancer-causing talc products faces a key test in a U.S.

JNJ

Read More
1 minute read
  • Legal
  • Management
  • News

The Teamsters Union Categorically Denies The Baseless Allegations Made By Yellow Corporation In Its Frivolous Lawsuit; Union Calls Out Freight Company For False Claims And Gross Mismanagement

By Happy Mohamed
June 27, 11:56 AM
Union Calls Out Freight Company for False Claims and Gross Mismanagement The Teamsters Union categorically denies the baseless allegations made by Yellow Corporation in its frivolous lawsuit filed today. "Yellow

YELL

Read More
3 minute read
  • Contracts
  • Legal
  • News

Yellow Corporation Files $137M+ Lawsuit Against International Brotherhood Of Teamsters, Alleging Breach Of Contract In Blocking Efforts To Modernize Century-Old Company

By Happy Mohamed
June 27, 8:24 AM
 Yellow Corporation (NASDAQ:YELL), the nation's third largest less than truckload (LTL) carrier and fifth largest transportation company, has filed a complaint in the U.S. District Court for the District of

YELL

Read More
1 minute read
  • Legal
  • News

Google Wants India’s Supreme Court To Scrap Competition Regulator’s Orders Against Android Dominance: Report

By Arpit Nayak
June 27, 8:06 AM
This story was first published on the Benzinga India Portal.

GOOG

Read More
1 minute read
  • Equities
  • General
  • Legal
  • Markets
  • Media
  • News

Former Audi Boss Sentenced In Volkswagen Diesel Scandal: Report

By Shivani Kumaresan
June 27, 5:53 AM
Former Chairman of Volkswagen (OTC: VWAGY) owned Audi, Rupert Stadler, has been given a suspended sentence of one year and nine months by a German court for fraud by negligence.

VWAGY

Read More
3 minute read
  • Cannabis
  • Events
  • Legal
  • Management
  • Markets
  • News
  • Psychedelics

World’s Largest Psychedelics Conference Sheds Light On Alternative Mental Health Therapies, Boasts 12K Attendees

By Lara Goldstein
June 26, 5:06 PM
The Multidisciplinary Association for Psychedelic Studies (MAPS) sponsored a Psychedelic Science conference in Denver last week, which gathered over 12,000 people from the entire psy

KONEF

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Legal
  • News

Merck & Co Accused of Underplaying Mental Health Risks from Asthma and Allergy Drug Singulair

By Vandana Singh
June 26, 2:25 PM
Initially, when released in 1998, Merck & Co Inc's (NYSE: MRK) asthma and allergy drug, Singulair, claimed side effects were mild and similar to a placebo, and the label stated that its distribution in the brain was "minimal," with no mention of psychiatric side effects.

MRK

Posts pagination

Previous 1 … 110 111 112 … 258 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service